Venture capital firm profile
Seroba
Seroba invests in biotechnology, medical devices and digital health companies, supporting entrepreneurs developing treatments and technologies that address unmet clinical needs.

Published Fund IV mandate (February 2024): predominantly Western Europe, selectively North America
current broader eligibility not specified.
Published Fund IV mandate targets early-stage life sciences, primarily biotech. Investee companies are asked to commit to impact themes on a best-effort basis and provide relevant ESG disclosures and assurances; an exclusion policy applies, but its full current schedule is unverified. Standard initial cheques, ownership percentages and fees are undisclosed. Email security/confidentiality is not assured; during investment due diligence Seroba says it will sign its NDA if requested.
Healthcare & Life Sciences
Published Fund IV mandate (February 2024): predominantly Western Europe, selectively North America
Sources checked
current broader eligibility not specified.
Sources checked
Published Fund IV mandate targets early-stage life sciences, primarily biotech. Investee companies are asked to commit to impact themes on a best-effort basis and provide relevant ESG disclosures and assurances; an exclusion policy applies, but its full current schedule is unverified. Standard initial cheques, ownership percentages and fees are undisclosed. Email security/confidentiality is not assured; during investment due diligence Seroba says it will sign its NDA if requested.
Sources checked
Healthcare & Life Sciences
As of
Sources checked
Seroba is a life-sciences venture investor headquartered in Dublin, with offices in Paris and Milan. Its portfolio spans therapeutics and medical technologies, and its investment approach combines capital with operational support and attention to patient outcomes, governance and sustainability.
Editorial profile by MoneyMakers. Sources reviewed . Profile source.
Ireland
Loading profile details…
Investment sectors
Healthcare & Life Sciences · Investment sectors
As of 2026-11-14
Seroba official sourceSeroba official sourceSeroba official sourceSeroba official sourceSeroba official sourceSeroba official sourceSeroba official sourceLoading recent changes…